$GSK Company News U.K. stocks pare losses after
Post# of 5326
Posted On: 11/12/2013 11:25:29 PM
$GSK Company News
U.K. stocks pare losses after inflation data 12:00 p.m. Today - Sara Sjolin
FTSE 100 climbs for third day, Aggreko rallies 1:31 p.m. Oct. 28, 2013 - Sara Sjolin
Glaxo, miners pull FTSE 100 from five-month high 12:26 p.m. Oct. 23, 2013 - Sara Sjolin
Banks hit Europe after ECB stress-test news 12:04 p.m. Oct. 23, 2013 - Sara Sjolin
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 11:45 a.m. Oct. 23, 2013 - blogs.marketwatch.com
GSK sales to China down 61% on bribery probe 7:42 a.m. Oct. 23, 2013 - MarketWatch.com
5 of the biggest corporate fines ever 2:40 p.m. Oct. 21, 2013 - Jonnelle Marte
GSK sells thrombosis brands to Aspen for $1.13 bln 7:46 a.m. Sept. 30, 2013 - MarketWatch.com
J.P. Morgan launches fund with Gates Foundation 10:17 a.m. Sept. 23, 2013 - MarketWatch.com
BlackBerry plunges as it slashes jobs, forecasts 4:57 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Two upgrades, two downgrades from Barclays on Euro drug makers 12:46 p.m. Sept. 16, 2013 - blogs.marketwatch.com
U.K.’s FTSE 100 rises to six-week high 12:40 p.m. Sept. 16, 2013 - Sara Sjolin
FDA votes for GSK, Thereavance lung-disease drug 2:50 a.m. Sept. 11, 2013 - MarketWatch.com
Mylan shares jump after FDA lays out guidelines for asthma generic 2:47 p.m. Sept. 10, 2013 - blogs.marketwatch.com
Miners, banks lead FTSE higher after China data 12:16 p.m. Sept. 10, 2013 - Sara Sjolin
European stocks rally after upbeat China data 12:10 p.m. Sept. 10, 2013 - Sara Sjolin
Asian shares rise on upbeat Chinese data 4:55 a.m. Sept. 10, 2013 - Daniel Inman
BG leads FTSE 100 lower after forecast downgrade 12:08 p.m. Sept. 9, 2013 - Sara Sjolin
GSK sells Lucozade, Ribena to Suntory for $2.1 bln 4:09 a.m. Sept. 9, 2013 - MarketWatch.com
U.S. expands Glaxo probe to include China 11:21 a.m. Sept. 7, 2013 - MarketWatch.com
GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks 11:56 a.m. Today - Wall St. Cheat Sheet
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) 10:25 a.m. Today - TheStreet.com
GSK Pivotal Phase III Study of Darapladib in Chronic Coronary Heart Disease Gid Not Meet Primary Endpoint 5:11 a.m. Today - benzinga.com
Pre-Market Activity Shows Heavy Volume And Movement For GlaxoSmithKline (GSK) 8:56 a.m. Nov. 11, 2013 - TheStreet.com
China Biotech In Review: Cytori Signs $531 Million Deal With New Australian Company 3:22 a.m. Nov. 10, 2013 - Seeking Alpha
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
GlaxoSmithKline: Offering Stable And Juicy Dividend Yield 1:42 p.m. Nov. 8, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Agenus Valuation After Positive HerpV Vaccine Results 2:46 p.m. Nov. 7, 2013 - Seeking Alpha
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
These 48 Blue Chips Are On the Move 4:40 a.m. Nov. 6, 2013 - InvestorPlace.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Will GlaxoSmithKline Get Away in China? 5:10 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Update on Glaxo's Respiratory Portfolio - Analyst Blog 4:30 p.m. Nov. 4, 2013 - Zacks.com
Johnson & Johnson Agrees to $2B DOJ Settlement 11:08 a.m. Nov. 4, 2013 - FOXBusiness
GlaxoSmithKline Dodges China Bullet, Dish-Disney Deal Remains Elusive, and 2 More Hot Stocks 11:07 a.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Why I'm More Confident in Sarepta Than Ever Before 10:06 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com
WPP'S GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline 3:26 p.m. Nov. 11, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Upcoming Presentations, New Studies, and Stock Price Movements - Research Report on WellPoint, GSK, Forest Laboratories, Intuitive Surgical, and Cubist Pharmaceuticals 8:00 a.m. Nov. 11, 2013 - PR Newswire
Cannabis Biotech Files Patent Application for Metered-Dose Dispensing Device 8:30 a.m. Nov. 4, 2013 - BusinessWire
Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection 5:52 p.m. Nov. 1, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD 10:09 a.m. Oct. 30, 2013 - PR Newswire
Critical Alerts For GlaxoSmithKline, Deutsche Bank, Cummins, Canadian Solar, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2013 - PR Newswire
BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD 9:01 a.m. Oct. 30, 2013 - Marketwire
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
FDA Approval, FDA Application, Positive Safety Results, and Presentations - Research Report on Cubist, GSK, Rockwell Medical, Arrowhead, and Horizon Pharma 8:00 a.m. Oct. 24, 2013 - PR Newswire
Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States 8:00 a.m. Oct. 23, 2013 - PR Newswire
GlaxoSmithKline CFO Interviewed on Q3 results 7:56 a.m. Oct. 23, 2013 - PR Newswire
ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV 12:53 p.m. Oct. 22, 2013 - PR Newswire
At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist 11:43 a.m. Oct. 22, 2013 - PR Newswire
Maxalt/Maxalt MLT is the Most Commonly Prescribed Branded Triptan Used by Newly Diagnosed Migraine Patients in the United States 10:00 a.m. Oct. 22, 2013 - PR Newswire
Cannabis Biotech Launches Development of Transmucosal Delivery System 8:30 a.m. Oct. 21, 2013 - BusinessWire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development 9:06 a.m. Oct. 8, 2013 - BusinessWire
U.K. stocks pare losses after inflation data 12:00 p.m. Today - Sara Sjolin
FTSE 100 climbs for third day, Aggreko rallies 1:31 p.m. Oct. 28, 2013 - Sara Sjolin
Glaxo, miners pull FTSE 100 from five-month high 12:26 p.m. Oct. 23, 2013 - Sara Sjolin
Banks hit Europe after ECB stress-test news 12:04 p.m. Oct. 23, 2013 - Sara Sjolin
Drug-maker earnings come in ahead of views, but stocks aren't rewarded 11:45 a.m. Oct. 23, 2013 - blogs.marketwatch.com
GSK sales to China down 61% on bribery probe 7:42 a.m. Oct. 23, 2013 - MarketWatch.com
5 of the biggest corporate fines ever 2:40 p.m. Oct. 21, 2013 - Jonnelle Marte
GSK sells thrombosis brands to Aspen for $1.13 bln 7:46 a.m. Sept. 30, 2013 - MarketWatch.com
J.P. Morgan launches fund with Gates Foundation 10:17 a.m. Sept. 23, 2013 - MarketWatch.com
BlackBerry plunges as it slashes jobs, forecasts 4:57 p.m. Sept. 20, 2013 - Saumya Vaishampayan
Two upgrades, two downgrades from Barclays on Euro drug makers 12:46 p.m. Sept. 16, 2013 - blogs.marketwatch.com
U.K.’s FTSE 100 rises to six-week high 12:40 p.m. Sept. 16, 2013 - Sara Sjolin
FDA votes for GSK, Thereavance lung-disease drug 2:50 a.m. Sept. 11, 2013 - MarketWatch.com
Mylan shares jump after FDA lays out guidelines for asthma generic 2:47 p.m. Sept. 10, 2013 - blogs.marketwatch.com
Miners, banks lead FTSE higher after China data 12:16 p.m. Sept. 10, 2013 - Sara Sjolin
European stocks rally after upbeat China data 12:10 p.m. Sept. 10, 2013 - Sara Sjolin
Asian shares rise on upbeat Chinese data 4:55 a.m. Sept. 10, 2013 - Daniel Inman
BG leads FTSE 100 lower after forecast downgrade 12:08 p.m. Sept. 9, 2013 - Sara Sjolin
GSK sells Lucozade, Ribena to Suntory for $2.1 bln 4:09 a.m. Sept. 9, 2013 - MarketWatch.com
U.S. expands Glaxo probe to include China 11:21 a.m. Sept. 7, 2013 - MarketWatch.com
GlaxoSmithKline Drug Falls Short, Sarepta Shares Collapse, and 3 More Hot Stocks 11:56 a.m. Today - Wall St. Cheat Sheet
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen (Updated) 10:25 a.m. Today - TheStreet.com
GSK Pivotal Phase III Study of Darapladib in Chronic Coronary Heart Disease Gid Not Meet Primary Endpoint 5:11 a.m. Today - benzinga.com
Pre-Market Activity Shows Heavy Volume And Movement For GlaxoSmithKline (GSK) 8:56 a.m. Nov. 11, 2013 - TheStreet.com
China Biotech In Review: Cytori Signs $531 Million Deal With New Australian Company 3:22 a.m. Nov. 10, 2013 - Seeking Alpha
4 Healthcare Sector Dogs Hype 13% To 17% October Upsides; 4% To 7.5% Downsides 7:02 p.m. Nov. 8, 2013 - Seeking Alpha
Make A Suave Move, Buy Novartis 2:37 p.m. Nov. 8, 2013 - Seeking Alpha
GlaxoSmithKline: Offering Stable And Juicy Dividend Yield 1:42 p.m. Nov. 8, 2013 - Seeking Alpha
Dynavax Reports In-Line Loss, Beats Rev - Analyst Blog 12:00 p.m. Nov. 8, 2013 - Zacks.com
Merck Looks Like a Relative Bargain 6:00 a.m. Nov. 8, 2013 - TheStreet.com
Agenus Valuation After Positive HerpV Vaccine Results 2:46 p.m. Nov. 7, 2013 - Seeking Alpha
Will GlaxoSmithKline Continue to Trend Higher? 8:29 a.m. Nov. 6, 2013 - Wall St. Cheat Sheet
These 48 Blue Chips Are On the Move 4:40 a.m. Nov. 6, 2013 - InvestorPlace.com
Ligand Pharmaceuticals On Pace For Annual Profit 4:25 p.m. Nov. 5, 2013 - Investors Business Daily
Will GlaxoSmithKline Get Away in China? 5:10 p.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Update on Glaxo's Respiratory Portfolio - Analyst Blog 4:30 p.m. Nov. 4, 2013 - Zacks.com
Johnson & Johnson Agrees to $2B DOJ Settlement 11:08 a.m. Nov. 4, 2013 - FOXBusiness
GlaxoSmithKline Dodges China Bullet, Dish-Disney Deal Remains Elusive, and 2 More Hot Stocks 11:07 a.m. Nov. 4, 2013 - Wall St. Cheat Sheet
Why I'm More Confident in Sarepta Than Ever Before 10:06 a.m. Nov. 4, 2013 - TheStreet.com
Pfizer's Not Losing Its Kingpin Status 6:00 a.m. Nov. 4, 2013 - TheStreet.com
WPP'S GO Team Awarded Tums and Eno Global Account by GlaxoSmithKline 3:26 p.m. Nov. 11, 2013 - PR Newswire
Morning Research: GlaxoSmithKline PLC, Keryx Biopharma Inc., AstraZeneca PLC, and Raptor Pharma Corp. 8:00 a.m. Nov. 11, 2013 - PR Newswire
Upcoming Presentations, New Studies, and Stock Price Movements - Research Report on WellPoint, GSK, Forest Laboratories, Intuitive Surgical, and Cubist Pharmaceuticals 8:00 a.m. Nov. 11, 2013 - PR Newswire
Cannabis Biotech Files Patent Application for Metered-Dose Dispensing Device 8:30 a.m. Nov. 4, 2013 - BusinessWire
Media Advisory: GSK Recalls Two Lots of Migraine Medication: IMITREX Injection 5:52 p.m. Nov. 1, 2013 - Marketwire
Dividend, Quarterly Report, Recognition, Study Results, and New Drug Application - Research Report on Pfizer, Lilly, Regeneron, Vertex, and GSK 9:00 a.m. Nov. 1, 2013 - PR Newswire
BREO® ELLIPTA(TM) now available in the U.S. for the treatment of COPD 10:09 a.m. Oct. 30, 2013 - PR Newswire
Critical Alerts For GlaxoSmithKline, Deutsche Bank, Cummins, Canadian Solar, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 30, 2013 - PR Newswire
BREO(R) ELLIPTA(TM) Now Available in the U.S. for the Treatment of COPD 9:01 a.m. Oct. 30, 2013 - Marketwire
Cannabis Biotech in Talks With Research Chemist to Explore Transmucosal Delivery 8:30 a.m. Oct. 29, 2013 - BusinessWire
FDA Approval, FDA Application, Positive Safety Results, and Presentations - Research Report on Cubist, GSK, Rockwell Medical, Arrowhead, and Horizon Pharma 8:00 a.m. Oct. 24, 2013 - PR Newswire
Lamotrigine is One of the Most Commonly Prescribed Drugs Among Newly Diagnosed Bipolar Disorder Patients in the United States 8:00 a.m. Oct. 23, 2013 - PR Newswire
GlaxoSmithKline CFO Interviewed on Q3 results 7:56 a.m. Oct. 23, 2013 - PR Newswire
ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV 12:53 p.m. Oct. 22, 2013 - PR Newswire
At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist 11:43 a.m. Oct. 22, 2013 - PR Newswire
Maxalt/Maxalt MLT is the Most Commonly Prescribed Branded Triptan Used by Newly Diagnosed Migraine Patients in the United States 10:00 a.m. Oct. 22, 2013 - PR Newswire
Cannabis Biotech Launches Development of Transmucosal Delivery System 8:30 a.m. Oct. 21, 2013 - BusinessWire
Financial Results, Quarterly Earnings Schedules, Marketing Authorizations, Completed Acquisitions, and New Drug Applications - Research Report on Johnson & Johnson, AbbVie, GSK, AstraZeneca, and Keryx 8:00 a.m. Oct. 18, 2013 - PR Newswire
Technical Study: AstraZeneca PLC, GlaxoSmithKline PLC, Keryx Biopharma Inc., and Raptor Pharma Corp. 12:51 p.m. Oct. 17, 2013 - PR Newswire
Medivir: Janssen Has Acquired an NS5a Replication Complex Inhibitor That Will Be Evaluated with Simeprevir in Future Clinical Development 9:06 a.m. Oct. 8, 2013 - BusinessWire
(0)
(0)